[144] Qualys, Inc. SEC Filing
Qualys, Inc. (QLYS) Form 144 discloses a proposed Rule 144 sale of 5,295 common shares with an aggregate market value of $714,295, scheduled approximately for 08/27/2025 on Nasdaq. The shares were acquired as vested restricted stock grants on 06/12/2020 and were paid as equity compensation.
The filing identifies Charles Schwab as the broker and reports related recent sales by John A. Zangardi: 1,287 shares sold for $169,918 on 08/13/2025 and 3,860 shares sold for $520,403 on 08/22/2025. The total outstanding shares reported in the filing are 36,095,879, and the filer certifies no undisclosed material adverse information.
Qualys, Inc. (QLYS) — La Form 144 segnala una proposta vendita ex Rule 144 di 5.295 azioni ordinarie per un valore complessivo di $714.295, prevista approssimativamente per il 27/08/2025 sul Nasdaq. Le azioni sono state ottenute come concessioni di azioni vincolate già maturate il 12/06/2020 e costituivano compenso in equity.
Il deposito indica Charles Schwab come intermediario e riporta vendite recenti correlate da parte di John A. Zangardi: 1.287 azioni vendute per $169.918 il 13/08/2025 e 3.860 azioni vendute per $520.403 il 22/08/2025. Le azioni totali in circolazione riportate nel documento sono 36.095.879 e il dichiarante certifica l'assenza di informazioni materiali negative non divulgate.
Qualys, Inc. (QLYS) — La Form 144 revela una propuesta de venta bajo la Rule 144 de 5.295 acciones ordinarias por un valor agregado de $714.295, prevista aproximadamente para el 27/08/2025 en Nasdaq. Las acciones fueron adquiridas como concesiones de acciones restringidas ya devengadas el 12/06/2020 y se trataron como compensación en acciones.
La presentación identifica a Charles Schwab como corredor y reporta ventas relacionadas recientes por parte de John A. Zangardi: 1.287 acciones vendidas por $169.918 el 13/08/2025 y 3.860 acciones vendidas por $520.403 el 22/08/2025. Las acciones totales en circulación informadas en la presentación son 36.095.879, y el declarante certifica que no hay información material adversa no divulgada.
Qualys, Inc. (QLYS) — Form 144는 Nasdaq에서 2025-08-27경에 예정된 총 시가 $714,295 상당의 5,295 보통주 매도를 Rule 144에 따라 신고합니다. 해당 주식은 2020-06-12에 이미 베스팅된 제한주 보조금으로 취득되었으며 주식 보상으로 지급되었습니다.
서류는 중개인으로 Charles Schwab를 명시하고, John A. Zangardi의 관련 최근 매도를 보고합니다: 2025-08-13에 1,287주를 $169,918에 매도, 2025-08-22에 3,860주를 $520,403에 매도했습니다. 신고서에 기재된 총 발행 주식수는 36,095,879주이며, 제출인은 공개되지 않은 중대한 불리한 정보가 없음을 인증합니다.
Qualys, Inc. (QLYS) — Le formulaire 144 divulgue une proposition de vente selon la Rule 144 de 5 295 actions ordinaires d'une valeur totale de 714 295 $, prévue approximativement pour le 27/08/2025 sur le Nasdaq. Les actions ont été acquises en tant que attributions d'actions restreintes déjà acquises le 12/06/2020 et versées comme rémunération en actions.
Le dépôt identifie Charles Schwab comme courtier et rapporte des ventes récentes connexes par John A. Zangardi : 1 287 actions vendues pour 169 918 $ le 13/08/2025 et 3 860 actions vendues pour 520 403 $ le 22/08/2025. Le nombre total d'actions en circulation indiqué est de 36 095 879, et le déclarant certifie l'absence d'informations défavorables importantes non divulguées.
Qualys, Inc. (QLYS) — In der Form 144 wird ein geplanter Verkauf gemäß Rule 144 von 5.295 Stammaktien mit einem Gesamtmarktwert von $714.295 gemeldet, vorgesehen etwa am 27.08.2025 an der Nasdaq. Die Aktien wurden am 12.06.2020 als vested restricted stock grants erworben und als Aktienvergütung ausgezahlt.
Die Einreichung nennt Charles Schwab als Broker und berichtet über damit zusammenhängende kürzliche Verkäufe durch John A. Zangardi: 1.287 Aktien für $169.918 am 13.08.2025 und 3.860 Aktien für $520.403 am 22.08.2025. Die im Dokument angegebene insgesamt ausstehende Aktienzahl beträgt 36.095.879, und der Einreicher bestätigt, dass keine nicht offengelegten wesentlichen negativen Informationen vorliegen.
- Transparent disclosure of proposed sale under Rule 144, including acquisition and payment details
- Recent sales reported with dollar amounts and dates, supporting market transparency and compliance
- None.
Insights
TL;DR Insider disclosed a small, routine sale of vested equity under Rule 144; transparency reduces informational asymmetry.
The filing documents a proposed sale of 5,295 shares valued at $714,295 originating from vested restricted stock grants dated 06/12/2020. The disclosure follows required procedures and notes two recent sales by the same named individual totaling 5,147 shares and roughly $690,321 in proceeds in August 2025. Given the shares outstanding figure (36,095,879), the sale size is immaterial on an absolute percentage basis and appears procedural rather than a company-specific signal.
TL;DR Filing reflects compliance with Rule 144; no governance red flags evident from disclosed items alone.
The notice indicates the securities were granted as equity compensation and that the seller attests to lack of undisclosed material adverse information. The involvement of a major broker and timely reporting of recent sales are consistent with standard insider selling practices. There is no information in the filing to suggest breaches of trading policy or undisclosed related-party transactions.
Qualys, Inc. (QLYS) — La Form 144 segnala una proposta vendita ex Rule 144 di 5.295 azioni ordinarie per un valore complessivo di $714.295, prevista approssimativamente per il 27/08/2025 sul Nasdaq. Le azioni sono state ottenute come concessioni di azioni vincolate già maturate il 12/06/2020 e costituivano compenso in equity.
Il deposito indica Charles Schwab come intermediario e riporta vendite recenti correlate da parte di John A. Zangardi: 1.287 azioni vendute per $169.918 il 13/08/2025 e 3.860 azioni vendute per $520.403 il 22/08/2025. Le azioni totali in circolazione riportate nel documento sono 36.095.879 e il dichiarante certifica l'assenza di informazioni materiali negative non divulgate.
Qualys, Inc. (QLYS) — La Form 144 revela una propuesta de venta bajo la Rule 144 de 5.295 acciones ordinarias por un valor agregado de $714.295, prevista aproximadamente para el 27/08/2025 en Nasdaq. Las acciones fueron adquiridas como concesiones de acciones restringidas ya devengadas el 12/06/2020 y se trataron como compensación en acciones.
La presentación identifica a Charles Schwab como corredor y reporta ventas relacionadas recientes por parte de John A. Zangardi: 1.287 acciones vendidas por $169.918 el 13/08/2025 y 3.860 acciones vendidas por $520.403 el 22/08/2025. Las acciones totales en circulación informadas en la presentación son 36.095.879, y el declarante certifica que no hay información material adversa no divulgada.
Qualys, Inc. (QLYS) — Form 144는 Nasdaq에서 2025-08-27경에 예정된 총 시가 $714,295 상당의 5,295 보통주 매도를 Rule 144에 따라 신고합니다. 해당 주식은 2020-06-12에 이미 베스팅된 제한주 보조금으로 취득되었으며 주식 보상으로 지급되었습니다.
서류는 중개인으로 Charles Schwab를 명시하고, John A. Zangardi의 관련 최근 매도를 보고합니다: 2025-08-13에 1,287주를 $169,918에 매도, 2025-08-22에 3,860주를 $520,403에 매도했습니다. 신고서에 기재된 총 발행 주식수는 36,095,879주이며, 제출인은 공개되지 않은 중대한 불리한 정보가 없음을 인증합니다.
Qualys, Inc. (QLYS) — Le formulaire 144 divulgue une proposition de vente selon la Rule 144 de 5 295 actions ordinaires d'une valeur totale de 714 295 $, prévue approximativement pour le 27/08/2025 sur le Nasdaq. Les actions ont été acquises en tant que attributions d'actions restreintes déjà acquises le 12/06/2020 et versées comme rémunération en actions.
Le dépôt identifie Charles Schwab comme courtier et rapporte des ventes récentes connexes par John A. Zangardi : 1 287 actions vendues pour 169 918 $ le 13/08/2025 et 3 860 actions vendues pour 520 403 $ le 22/08/2025. Le nombre total d'actions en circulation indiqué est de 36 095 879, et le déclarant certifie l'absence d'informations défavorables importantes non divulguées.
Qualys, Inc. (QLYS) — In der Form 144 wird ein geplanter Verkauf gemäß Rule 144 von 5.295 Stammaktien mit einem Gesamtmarktwert von $714.295 gemeldet, vorgesehen etwa am 27.08.2025 an der Nasdaq. Die Aktien wurden am 12.06.2020 als vested restricted stock grants erworben und als Aktienvergütung ausgezahlt.
Die Einreichung nennt Charles Schwab als Broker und berichtet über damit zusammenhängende kürzliche Verkäufe durch John A. Zangardi: 1.287 Aktien für $169.918 am 13.08.2025 und 3.860 Aktien für $520.403 am 22.08.2025. Die im Dokument angegebene insgesamt ausstehende Aktienzahl beträgt 36.095.879, und der Einreicher bestätigt, dass keine nicht offengelegten wesentlichen negativen Informationen vorliegen.